Cargando…
Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells
Colon cancer is the third most commonly diagnosed cancer in the world, and it is the major cause of morbidity and mortality throughout the world. The present study aimed at treating colon cancer cell line (HCT116) with different chemotherapeutic drug/drug combinations (procaine, vorinostat “SAHA,” s...
Autores principales: | Sabit, Hussein, Samy, Mariam B., Said, Osama A. M., El-Zawahri, Mokhtar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098101/ https://www.ncbi.nlm.nih.gov/pubmed/27843649 http://dx.doi.org/10.1155/2016/8348450 |
Ejemplares similares
-
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
por: Sohn, Won Jun, et al.
Publicado: (2010) -
Entrainment of superoxide rhythm by menadione in HCT116 colon cancer cells
por: Kizhuveetil, Uma, et al.
Publicado: (2019) -
DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis
por: Sha, Mingquan, et al.
Publicado: (2015) -
Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer Cells
por: Karabay, Arzu Zeynep, et al.
Publicado: (2016) -
The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells
por: Fahmy, Usama A., et al.
Publicado: (2020)